PRospective Evaluation of Complete Revascularization in Patients With multiveSsel Disease Excluding chroNic Total Occlusions

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 609 participants.

Also called NCT05230446

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 609 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05230446
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05230446. Allocation not applicable; no masking; primary purpose treatment. Start 2021-11-18 (actual); primary completion 2023-11-18 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
PRospective Evaluation of Complete Revascularization in Patients With multiveSsel Disease Excluding chroNic Total Occlusions
Acronym
PRESENT
Condition
Multi Vessel Coronary Artery Disease
Condition
Non-ST Elevation Myocardial Infarction
Condition
Unstable Angina
Condition
Stable Angina
Condition
Optical Coherence Tomography
Intervention (Device)
PCI (percutaneous coronary intervention) with OCT guidance
Lead sponsor
Erasmus Medical Center (class: other)

Record details

Record id
cardio:ct-nct05230446
Content hash
f7c5a97ab2c2023661e994ef47c1a6ebd4d404516c9992d3724770061db279fe